Back to search results

Pounce™ Thrombectomy System for Peripheral Arterial Disease and Acute Limb Ischemia

This study is looking back at information from patients who have already received treatment with the Pounce™ Thrombectomy System. This system is a device used to non-surgically remove blood clots (thrombi) and blockages (emboli) from arteries in the legs and arms (peripheral arterial vasculature). The study aims to understand how successful the procedure is and if there are any device-related serious problems (Major Adverse Events) within 30 days. You could be included in this study if you are 18 years or older, have had this procedure, and are able to provide consent for your data to be used. This study is currently gathering information and is not actively recruiting new patients for treatment.

Study design
This is an observational study, meaning researchers are looking at existing patient data. It is an open-label, multi-center study in the US, planning to include information from about 500 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Researchers will look at information about any device-related serious problems for up to 30 days after the procedure.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05868161

Pounce™ Thrombectomy System Retrospective Registry

Recruiting
Not specifiedAges 18+Observational
SurModics, Inc.
~500 participants
Updated 2025-09-11 on ClinicalTrials.gov
What's tested:Pounce Thrombectomy System

At a glance

Recruiting sites
7 of 9 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Procedural Success
Measured over Peri-procedural (by the end of the index procedure)
+1 more outcome measured

Conditions

Peripheral Arterial Disease
Acute Limb Ischemia

Explore related trials

Limb ischemiaPeripheral Artery Disease

Where it's being run

9 sites across 9 states
Illinois1
Indiana1
Louisiana1
Minnesota1
Ohio1
South Carolina1
South Dakota1
Tennessee1

Study leadership

  • Sean Lyden, MD · PRINCIPAL_INVESTIGATOR · The Cleveland Clinic
  • Joseph Campbell, MD · PRINCIPAL_INVESTIGATOR · OhioHealth

Who to contact

Clinical Program Manager
[email protected]
1-866-787-6639
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Subject underwent an endovascular intervention where the Pounce Thrombectomy System was attempted
Subject is willing and able to provide informed consent prior to the collection of study data or a consent waiver is in place

Exclusion

Subject is under the age of 18 years

What this trial measures

  • Procedural SuccessPeri-procedural (by the end of the index procedure)

    Restoration of pulsatile flow in the target lesion(s) with or without adjunctive treatment as determined by the core lab and physician

  • Incidence of device related Major Adverse Events (MAEs)Procedure to 30 days

    Death, Unplanned major amputation (above ankle), Clinically Driven target lesion revascularization (TLR)